pediatric ophthalmology

Long-Term Outcomes of Strabismus Surgery in Children with Perinatal Brain Injury: Insights and Clinical Implications

By MedXY 08/24/2026

Children with perinatal brain injury exhibit lower long-term success rates following strabismus surgery, mainly due to undercorrection despite comparable surgical dosing. Larger preoperative deviations predict poorer outcomes, underscoring the need for tailored counseling and treatment strategies.

Clinical Updates news Ophthalmology Pediatrics

Efficacy and Safety of Dual-Sided Composite Defocus Spectacles for Pediatric Myopia Control: A Comprehensive Evidence Review

By MedXY 08/12/2026

This review synthesizes evidence on dual-sided composite defocus (DSCD) spectacle lenses, demonstrating significant myopia progression reduction and axial elongation control in children, contextualized within broader spectacle-based interventions and mechanistic insights.

news Ophthalmology Pediatrics

Global Axial Length Centile Charts: A New Reference for Myopia Management in Children and Adolescents

By MedXY 08/06/2026

New region- and sex-specific axial length centile charts provide vital reference values for myopia monitoring and management in children, highlighting regional differences and supporting targeted interventions against rising myopia rates.

Clinical Updates news Ophthalmology Pediatrics

Persistent Challenges in Managing Monocular Deprivation Amblyopia: A Three-Decade Trend Analysis of Infant Unilateral Cataract Outcomes

By MedXY 05/13/2026

This review evaluates 30 years of clinical outcomes for monocular congenital cataracts, revealing stagnant visual acuity results, high surgical burdens, and significant rates of secondary glaucoma and nystagmus despite surgical advances.

news Ophthalmology Pediatrics

Web-Based Amblyopia Decision Support Tool

By MedXY 05/11/2026

The Amblyopia Navigator offers evidence-based guidance for eye care professionals to improve early detection and treatment of childhood amblyopia, addressing specialist shortages through accessible digital tools.

news Ophthalmology Pediatrics

Understanding the FDA’s Rejection of SYD-101: Navigating the Challenges in Pediatric Myopia Treatment

By MedXY 11/04/2025

The FDA has rejected Sydnexis's low-dose atropine eye drop SYD-101 for controlling childhood myopia progression despite promising trial results, highlighting challenges in demonstrating long-term efficacy and clinical significance in new pediatric myopia therapies.

Clinical Updates news Ophthalmology Specialties

Diversified Segmental Defocus Optimization Lenses With and Without Atropine: A New Frontier in Myopia Prevention

By MedXY 09/11/2025

A recent randomized clinical trial demonstrates that diversified segmental defocus optimization (DSDO) spectacle lenses significantly reduce the onset and progression of myopia in children, with or without adjunct low-dose atropine.